Evidence map›Paper›PMID 40185909›Full record

ArticleScientific reports2025

A quantum inspired machine learning approach for multimodal Parkinson's disease screening.

Diya Vatsavai, Anya Iyer, Ashwin A Nair

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Mathematical proof of the Fisher-EscolàComputational and structural biotechnology journal · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Diya VatsavaiValley Christian High School, San Jose, CA, USA.
Anya IyerDougherty Valley High School, San Ramon, CA, USA.
Ashwin A NairUC Davis Graduate School of Management, Davis, CA, USA. aaravind@ucdavis.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease, currently the fastest-growing neurodegenerative disorder globally, has seen a 50% increase in cases within just two years. As disease progression impairs speech, memory, and motor functions over time, early diagnosis is crucial for preserving patients' quality of life. Although machine-learning-based detection has shown promise for detecting Parkinson's disease, most studies rely on a single feature for classification and can be error-prone due to the variability of symptoms between patients. To address this limitation we utilized the mPower dataset, which includes 150,000 samples across four key biomarkers: voice, gait, tapping, and demographic data. From these measurements, we extracted 64 features and trained a baseline Random Forest model to select the features above the 80th percentile. For classification, we designed a simulatable quantum support vector machine (qSVM) that detects high-dimensional patterns, leveraging recent advancements in quantum machine learning. With this novel and simulatable architecture that can be run on standard hardware rather than resource-intensive quantum computers, our model achieves an accuracy of 90%, F-1 score of 0.90, and an AUC of 0.98-surpassing benchmark models. Utilizing an innovative classification framework built on a diverse set of features, our model offers a pathway for accessible global Parkinson's screening.

Indexed as

Machine LearningParkinson DiseaseBiomarkersHumansMaleSupport Vector MachineBiomarkers

Identifiers

PMID40185909
PMCPMC11971407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.